Montebasto in Kenya

Product Overview

Montebasto is a prescription medication containing Montelukast, a leukotriene receptor antagonist used to manage:

• Asthma (chronic maintenance and prevention of exercise-induced bronchospasm).
• Allergic Rhinitis (seasonal or perennial, including nasal congestion, sneezing, and itching).
• Urticaria (chronic hives).
  Approved by the Kenya Pharmacy and Poisons Board (PPB), Montebasto works by blocking leukotrienes—chemicals that cause inflammation, bronchoconstriction, and allergy symptoms. It is available as tablets (10mg for adults, 5mg for children, 4mg chewable for young children) and is not a rescue inhaler for acute asthma attacks.

Composition

Each tablet contains:

• Active Ingredient: Montelukast Sodium (10mg, 5mg, or 4mg).
• Inactive Ingredients: Microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and colorants (e.g., ferric oxide).

Key Benefits:

• Asthma Control: Reduces frequency of attacks and need for rescue inhalers.
• 24-Hour Allergy Relief: Alleviates nasal/eye symptoms without drowsiness.
• Preventive Action: Taken once daily for long-term management.

How to Use

Dosage & Administration:

1. Asthma:
   • Adults & Adolescents (≥15 years): 10mg tablet once daily in the evening.
   • Children (6–14 years): 5mg chewable tablet once daily.
   • Children (2–5 years): 4mg chewable tablet once daily.
2. Allergic Rhinitis:
   • Same dosing as above; taken at the same time daily.
3. Administration:
   • Swallow whole with water (or chew for pediatric formulations).
   • Can be taken with or without food.
   • Consistency is critical—take at the same time each evening for optimal effect.

Critical Precautions:

• Not for Acute Attacks: Use a rescue inhaler (e.g., salbutamol) during asthma exacerbations.
• Avoid in:
  • Acute asthma attacks or status asthmaticus.
  • Phenylketonuria (chewable tablets contain aspartame).
• Pregnancy/Breastfeeding: Use only if benefits outweigh risks (consult doctor).

Side Effects

Montebasto is generally well-tolerated but may cause:

• Common:
  • Headache, dizziness, fatigue.
  • Abdominal pain, nausea, diarrhea.
  • Mild rash or itching.
• Serious (Seek Immediate Help):
  • Neuropsychiatric Effects: Agitation, aggression, hallucinations, depression, suicidal thoughts (rare but critical—monitor mood changes).
  • Severe Allergy: Anaphylaxis (swelling, breathing difficulties).
  • Eosinophilic Conditions: Vasculitis, Churg-Strauss syndrome (symptoms: numbness, persistent sinusitis).
  • Liver Issues: Jaundice, dark urine (discontinue use).

Black Box Warning:

• Neuropsychiatric Risks: Montelukast has been linked to serious behavioral changes, especially in children/adolescents. Discontinue immediately if mood disturbances occur.

Frequently Asked Questions (FAQs)

Q1: Where can I buy Montebasto in Kenya?
A: Available at major pharmacies (Goodlife, Medplus, Lifestores) and hospitals (e.g., Nairobi Hospital, Aga Khan) with a prescription. Online via MyDawa or Jumia.

Q2: What is the price of Montebasto in Kenya?
A:

• Montebasto 10mg (30 tablets): KES 1,500–2,000.
• Montebasto 5mg (30 tablets): KES 1,200–1,600.
  Generic versions (e.g., Montair) cost 30–40% less.

Q3: Is Montebasto covered by NHIF in Kenya?
A: Rarely covered unless prescribed for severe asthma under specialist care. Confirm with your insurer.

Q4: Can I use Montebasto for cold-induced asthma?
A: Yes, but it is preventive. For acute symptoms, use a bronchodilator (e.g., salbutamol).

Q5: How long until it works?
A: Asthma control may take 1 week; full effects in 2–4 weeks. Allergy relief starts within 24 hours.

Q6: Are there alternatives?
A: Yes:

• Zafirlukast (Accolate).
• Zileuton (Zyflo).
• Antihistamines (e.g., cetirizine) for allergies alone.

Q7: Can I stop Montebasto abruptly?
A: No. Taper under medical guidance to avoid symptom rebound.

Q8: Is it safe for long-term use?
A: Yes, for chronic conditions. Regular monitoring (every 3–6 months) is advised.

Conclusion

Montebasto is a cornerstone therapy for asthma and allergies in Kenya, offering once-daily convenience and non-drowsy relief. Its ability to prevent asthma attacks and reduce reliance on rescue inhalers makes it invaluable for chronic management. However, neuropsychiatric risks demand vigilance—especially in children. Always use under medical supervision, report mood changes immediately, and never replace emergency inhalers with Montebasto.

For Safe Use:

• Store below 30°C away from moisture.
• Monitor mental health closely, especially in young users.
• Combine with lifestyle measures: Avoid allergens, maintain smoke-free environments, and use spacer devices with inhalers.
• Choose generics for affordability (same efficacy as branded Montebasto).

Breathe easier and live allergy-free—consult your pulmonologist or allergist today!